Chemistry Reference
In-Depth Information
48. Weizman Z, Asli G, and Alsheikh A. Effect of a probiotic infant formula on infections in
child care centers: Comparison of two probiotic agents.
Pediatrics
, 115(1):5-9, 2005.
49. Arvola T, Laiho K, and Torkkeli S, et al. Prophylactic
Lactobacillus
GG reduces anti-
biotic-associated diarrhea in children with respiratory infections: A randomized study.
Pediatrics
, 104(5):e64, 1999.
50. Vanderhoof JA, Whitney DB, and Antonson DL, et al.
Lactobacillus
GG in the preven-
tion of antibiotic-associated diarrhea in children.
J Pediatr
, 135(5):564-68, 1999.
51. Szajewska H and Mrukowicz J. Meta-analysis: Non-pathogenic yeast
Saccharomyces
boulardii
in the prevention of antibiotic-associated diarrhoea.
Aliment Pharmacol Ther
,
22(5):365-72, 2005.
52. Tankanow R, Ross M, and Ertel I, et al. A double-blind, placebo-controlled study of the
efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea.
DICP
, 24(4):382-
84, 1990.
53. Biller JA, Katz AJ, and Flores AF, et al. Treatment of recurrent
Clostridium difficile
colitis with
Lactobacillus
GG.
J Pediatr Gastroenterol Nutr
, 21(2):224-26, 1995.
54. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral
administration of
Lactobacillus acidophilus
and
Bifidobacterium infantis
to neonates in
an intensive care unit.
Int J Infect Dis
, 3(4):197-202, 1999.
55. Bin-Nun A, Bromiker R, and Wilschanski M, et al. Oral probiotics prevent necrotizing
enterocolitis in very low birth weight neonates.
J Pediatr
, 147(2):192-96, 2005.
56. Lin H, Su B, and Chen A, et al. Oral probiotics reduce the incidence and severity of
necrotizing enterocolitis in very low birth weight infants.
Pediatrics
, 115(1):1-4, 2005.
57. Dani C, Biadaioli R, and Bertini G, et al. Probiotics feeding in prevention of urinary
tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A pro-
spective double-blind study.
Biol Neonate
, 82(2):103-8, 2002.
58. Isolauri E, Arvola T, and Sutas Y, et al. Probiotics in the management of atopic eczema.
Clin Exp Allergy
, 30(11):1604-10, 2000.
59. Kalliomaki M, Salminen S, and Arvilommi H, et al. Probiotics in primary prevention
of atopic disease: A randomised placebo-controlled trial.
Lancet
, 357(9262):1076-79,
2001.
60. Kalliomaki M, Salminen S, and Poussa T, et al. Probiotics and prevention of atopic dis-
ease: 4-year follow-up of a randomised placebo-controlled trial.
Lancet
, 361(9372):1869-
71, 2003.
61. Rosenfeldt V, Benfeldt E, and Nielsen S, et al. Effect of probiotic
Lactobacillus
strains
in children with atopic dermatitis.
J Allergy Clin Immunol
, 111(2):389-95, 2003.
62. Majamaa H and Isolauri E. Probiotics: A novel approach in the management of food
allergy.
J Allergy Clin Immunol
, 99(2):179-85, 1997.
63. Wang M, Lin H, and Wang Y, et al. Treatment of perennial allergic rhinitis with lactic
acid bacteria.
Pediatr Allergy Immunol
, 15(2):152-58, 2004.
64. Helin T, Haahtela S, and Haahtela T. No effect of oral treatment with an intestinal bacte-
rial strain,
Lactobacillus rhamnosus
(ATCC 53103), on birch-pollen allergy: A placebo-
controlled double-blind study.
Allergy
, 57(3):243-46, 2002.
65. Jung L.
Lactobacillus
GG augments the immune response to typhoid vaccination: A
double-blinded, placebo-controlled study.
FASEB J
, 13, 1999.
66. Isolauri E, Joensuu J, and Suomalainen H, et al. Improved immunogenicity of oral D x
RRV reassortant rotavirus vaccine by
Lactobacillus casei
GG.
Vaccine
, 13(3):310-12,
1995.
